These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36933099)

  • 1. Meta-analysis of HMGB1 levels in the cerebrospinal fluid and serum of patients with epilepsy.
    Chen Y; Chen X; Liang Y
    Neurol Sci; 2023 Jul; 44(7):2329-2337. PubMed ID: 36933099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of MMP-9 levels in the serum of patients with epilepsy.
    Wang Q; Lin Z; Yao C; Liu J; Chen J; Diao L
    Front Neurosci; 2024; 18():1296876. PubMed ID: 38449733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between high-mobility group box 1 levels and febrile seizures in children: a systematic review and meta-analysis.
    Li S; Zhao Q; Sun J; Yan W; Wang J; Gao X; Li X; Ren C; Hao L
    Sci Rep; 2023 Mar; 13(1):3619. PubMed ID: 36869074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased levels of HMGB1 and pro-inflammatory cytokines in children with febrile seizures.
    Choi J; Min HJ; Shin JS
    J Neuroinflammation; 2011 Oct; 8():135. PubMed ID: 21989210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of High-mobility group box 1 levels and multiple sclerosis: A systematic review and meta-analysis.
    Zhen C; Wang Y; Li D; Zhang W; Zhang H; Yu X; Wang X
    Mult Scler Relat Disord; 2019 Jun; 31():87-92. PubMed ID: 30953953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of circulating blood HMGB1 levels with ischemic stroke: a systematic review and meta-analysis.
    Le K; Mo S; Lu X; Idriss Ali A; Yu D; Guo Y
    Neurol Res; 2018 Nov; 40(11):907-916. PubMed ID: 30015578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of HMGB-1 and sTLR4 levels in cerebrospinal fluid of patients with febrile seizures.
    Kaya MA; Erin N; Bozkurt O; Erkek N; Duman O; Haspolat S
    Epilepsy Res; 2021 Jan; 169():106516. PubMed ID: 33276244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High mobility group box 1 enhances hyperthermia-induced seizures and secondary epilepsy associated with prolonged hyperthermia-induced seizures in developing rats.
    Ito M; Takahashi H; Yano H; Shimizu YI; Yano Y; Ishizaki Y; Tanaka J; Ishii E; Fukuda M
    Metab Brain Dis; 2017 Dec; 32(6):2095-2104. PubMed ID: 28879430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between high-mobility group box 1 levels and preeclampsia: a systematic review and meta-analysis.
    Xue L; Chen R; Zhou J; Lin W; Cai R; Liu Y; Zeng F; Zhang J; Chen H
    J Assist Reprod Genet; 2024 Mar; 41(3):551-561. PubMed ID: 38200286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF high-mobility group box 1 is associated with drug-resistance and symptomatic etiology in adult patients with epilepsy.
    Wang N; Liu H; Ma B; Zhao T; Chen Y; Yang Y; Zhao P; Han X
    Epilepsy Res; 2021 Nov; 177():106767. PubMed ID: 34543830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of serum/plasma high mobility group box 1 with autoimmune diseases: A systematic review and meta-analysis.
    Zhu B; Zhu Q; Li N; Wu T; Liu S; Liu S
    Medicine (Baltimore); 2018 Jul; 97(29):e11531. PubMed ID: 30024540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between serum levels of high mobility group box-1 protein and pancreatitis: a meta-analysis.
    Lin Y; Lin LJ; Jin Y; Cao Y; Zhang Y; Zheng CQ; Liu JL; Yang SL
    Biomed Res Int; 2015; 2015():430185. PubMed ID: 25695079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of serum high-mobility group box 1 concentration in dogs with epilepsy: A case-control study.
    Koo Y; Kim H; Yun T; Jung DI; Kang JH; Chang D; Na KJ; Yang MP; Kang BT
    J Vet Intern Med; 2020 Nov; 34(6):2545-2554. PubMed ID: 33150666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentration of high-mobility group box 1, Toll-like receptor 4 as biomarker in epileptic patients.
    Yue Z; Tang J; Peng S; Cai X; Rong X; Yang L
    Epilepsy Res; 2023 May; 192():107138. PubMed ID: 37075527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No association between HMGB1 polymorphisms and cancer risk: evidence from a meta-analysis.
    Li XY; Liang CH; Yang YJ; Liu L; Du YJ; Liang HS; Li L; Zhang B; Li JM; Zhao JM
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30049847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum HMGB1 in febrile seizures.
    Hautala MK; Mikkonen KH; Pokka TML; Rannikko SK; Koskela UV; Rantala HMJ; Uhari MK; Glumoff V; Helander HM
    Epilepsy Res; 2024 Jul; 203():107381. PubMed ID: 38772303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated Blood-Based Brain Biomarker Levels in Patients with Epileptic Seizures: A Systematic Review and Meta-analysis.
    Simani L; Sadeghi M; Ryan F; Dehghani M; Niknazar S
    ACS Chem Neurosci; 2020 Dec; 11(24):4048-4059. PubMed ID: 33147022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Mobility Group Protein B1 (HMGB1) and Interleukin-1β as Prognostic Biomarkers of Epilepsy in Children.
    Zhu M; Chen J; Guo H; Ding L; Zhang Y; Xu Y
    J Child Neurol; 2018 Dec; 33(14):909-917. PubMed ID: 30303442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic drug management for febrile seizures in children.
    Offringa M; Newton R; Nevitt SJ; Vraka K
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD003031. PubMed ID: 34131913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.